235 497

Cited 0 times in

그람양성균이 의심되거나 증명된 피부 및 연조직 감염증의 치료에 대한 Linezolid의 효능과 안전성

Other Titles
 The Efficacy and Safety of Linezolid for the Treatment of Suspected or Proven Gram Positive Skin and Soft Tissue Infections 
Authors
 엄중식  ;  이혁  ;  신동현  ;  김양리  ;  김신우  ;  이충기  ;  송재훈  ;  김준명  ;  강문원  ;  김우주 
Citation
 INFECTION AND CHEMOTHERAPY (감염과 화학요법), Vol.37(2) : 84-91, 2005 
Journal Title
INFECTION AND CHEMOTHERAPY (감염과 화학요법)(감염과 화학요법)
ISSN
 1598-8112 
Issue Date
2005
MeSH
Linezolid ; Skin and soft tissue infection ; Efficacy ; Safety
Keywords
Linezolid ; Skin and soft tissue infection ; Efficacy ; Safety
Abstract
Background: Linezolid, an oxazolidinone, has shown efficacy in the treatment of adults with nosocomial or community-acquired pneumonia, skin and soft tissue infections (SSTI), and infections due to methicillin-resistant Staphylococcus aureus. We have taken part in the study for evaluation of efficacy and safety of linezolid for the treatment of suspected or proven gram-positive SSTI in Asia. We sub-analyzed and reported the results of the study among Korean patients.
Materials and Methods: A total of 60 patients were enrolled in the study for evaluation of efficacy and safety of linezolid for the treatment of gram-positive SSTI at eight teaching hospitals in Korea. We investigated patients' medical history, physical examination and laboratory study. Patients were regularly followed up to evaluate clinical response, laboratory changes, and adverse event up to 4 weeks after treatment. When possible, we performed microbiological study before and after treatment.
Results: A total of 60 patients were enrolled. Average age of the patient was 50.9±15.3 years old with male to female ratio being 1.3:1. Cellulitis, open wound infection, skin abscess, and other clinical manifestations were observed in 47 (78.3%), 6 (10.0%), 2 (3.3%), and 5 (8.3%) patients, respectively. Forty two patients completed both follow-up and treatment and among them, treatment was successful in 38 patients (90.5%) and unsuccessful in 4 patients (9.5%). Microoranisms were isolated from seven patients and 14 isolates were documented; 11 S. aureus, 3 coagulase-negative staphylococcus. Among the seven patients, bacteria were eradicated in four patient and the organism proved to be colonization in three patients. The most frequent drug-related adverse events were gastrointestinal (21.7%), hematologic and biochemical (21.7%) and neurologic (3.3%), in decreasing order. Nausea (15%) was the most frequent symptom and there were no serious side effects related to linezolid.
Conclusion: Linezolid was effective and safe in treatment of gram-positive SSTI.
Files in This Item:
T200501127.pdf Download
DOI
OAK-2005-05520
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Kim, June Myung(김준명)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/151266
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links